Evelo Biosciences, Inc. Stock
Stocks
EVLO
US2997342025
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -80.00% |
|
-.--% | -80.00% |
| 14/12/23 | Evelo Biosciences, Inc.(OTCPK:EVLO) dropped from S&P TMI Index | CI |
| 11/12/23 | Evelo Biosciences, Inc.(OTCPK:EVLO) dropped from NASDAQ Biotechnology Index | CI |
| Market Cap | 1.17M 1.01M 944K 867K 1.64M 111M 1.66M 11.13M 4.37M 55.44M 4.38M 4.28M 186M | P/E 2021 |
-2.63x | P/E 2022 | -1.23x |
|---|---|---|---|---|---|
| Enterprise Value | 4.36M 3.79M 3.53M 3.24M 6.12M 417M 6.22M 41.63M 16.34M 207M 16.39M 16.03M 696M | EV / Sales 2021 |
-
| EV / Sales 2022 | - |
| Free-Float |
100% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -80.00% | ||
| Current month | -66.67% | ||
| 3 months | -66.67% | ||
| 6 months | -50.00% | ||
| Current year | -80.00% |
| 1 week | 0 |  | 0 |
| 1 month | 0 | | 0 |
| Current year | 0 | | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 13.93 |
| 5 years | 0 | | 254.8 |
| 10 years | 0 | | 398.57 |
| Manager | Title | Age | Since |
|---|---|---|---|
Craig Jalbert
CEO | Chief Executive Officer | 64 | 21/11/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Craig Jalbert
BRD | Director/Board Member | 64 | 21/11/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/11/23 | Fiscal year | Chief Financial Officer | 14,811 | 0.0786% | ||
| 7/11/23 | Fiscal year | Chief Executive Officer | 2,516 | 0.0134% | ||
| 7/11/23 | Fiscal year | Chief Technology Officer | 16,413 | 0.0871% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -80.00% | -.--% | -80.00% | -100.00% | 5.69K | |
| +2.35% | +2.74% | +38.10% | +71.29% | 56.54B | |
| -0.21% | -7.38% | +27.52% | +61.15% | 53.6B | |
| -2.44% | +1.40% | -15.61% | -15.45% | 22.91B | |
| -2.85% | -7.78% | -9.28% | +345.55% | 21.37B | |
| +2.49% | -0.92% | +23.57% | -13.14% | 20.27B | |
| +0.79% | -1.06% | +33.99% | -31.95% | 17.56B | |
| +0.58% | -5.88% | +19.40% | +527.50% | 14.75B | |
| +3.41% | -6.61% | +162.81% | +278.22% | 13.53B | |
| -5.25% | -4.23% | +42.32% | +170.15% | 13.33B | |
| Average | -8.11% | -3.41% | +24.28% | +129.33% | 23.39B | |
| Weighted average by Cap. | +0.23% | -2.96% | +30.79% | +116.84% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | - | - |
| Net income | -122M -106M -98.86M -90.76M -171M -11.66B -174M -1.17B -457M -5.81B -459M -449M -19.47B | -115M -99.56M -92.67M -85.08M -161M -10.93B -163M -1.09B -429M -5.44B -430M -421M -18.25B |
| Net Debt | -12.15M -10.56M -9.83M -9.02M -17.04M -1.16B -17.31M -116M -45.47M -577M -45.62M -44.62M -1.94B | 3.2M 2.78M 2.59M 2.38M 4.49M 305M 4.56M 30.5M 11.97M 152M 12.01M 11.75M 510M |
Employees
66
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- EVLO Stock
Select your edition
All financial news and data tailored to specific country editions
